| Index | Ligand Name | Structure | PDB code | Compound Potency nM |
| 1 | 7ys | Crystal structure of the Mer kinase domain in complex with a macrocyclic inhibitor | 5u6c | 0.05 |
| 2 | 7ae | Structure-based optimization of 1H-imidazole-2-carboxamides as Axl kinase inhibitors utilizing a Mer mutant surrogate | 5td2 | 2.2 |
| 3 | ckj | Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC569 | 3tcp | 4.3 |
| 4 | k0x | Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC2541 | 5k0x | 4.4 |
| 5 | 4mh | Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC1817 | 4mha | 5.2 |
| 6 | 24k | Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC1917 | 4m3q | 17 |
| 7 | 79y | Structure-based optimization of 1H-imidazole-2-carboxamides as Axl kinase inhibitors utilizing a Mer mutant surrogate | 5tc0 | 25 |
| 8 | mh7 | Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC1896 | 4mh7 | 5900 |
| 9 | olp | Crystal structure of catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor C52 | 3bpr | 1.13e+004 |